Tradestie Institutional Equity Comparison Engine
ACAD vs BANX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BANX Overall Edge
BANX Captures Institutional Edge (4โ0 Pillars ยท 4โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ArrowMark Financial Corp. Common Stock (BANX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ACAD trades at 15.8x Forward P/E with 10.2% operating margin (+22.8% YoY revenue) versus BANX at 14.6x Forward P/E and 75.4% operating margin (-0.2% YoY). In options structure, ACAD sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against BANX sits in UNCLASSIFIED (14th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
BANX
ACAD 15.8x vs BANX 14.6x Fwd P/E
Growth & Margin Winner
BANX
Op Margin 10.2% vs 75.4% ยท YoY +22.8% vs -0.2%
Momentum & Technical Winner
BANX
1Y -25.9% vs -11.2% ยท 52W Pos 8% vs 8%
Options & Structure Winner
BANX
BREAKDOWN (6th %ile IV) vs UNCLASSIFIED (14th %ile IV)
ACAD
NASDAQ
Acadia Pharmaceuticals Inc.
Pharmaceutical Preparations
$17.11
-2.73% 1D
Market Cap
$3.0B
1M Return
-15.76%
1Y Return
-25.93%
Forward P/E
15.8x
Unified AI Score
44.8 / 100
HOLD
Tech 38.0
Fund 54.0
Flow 67.0
Mom 60.0
BANX
NASDAQ
ArrowMark Financial Corp. Common Stock
Institutional Equity
$18.79
-0.74% 1D
Market Cap
$183.4M
1M Return
-6.1%
1Y Return
-11.16%
Forward P/E
14.6x
Unified AI Score
39.5 / 100
SELL
Tech 28.0
Fund 46.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ACAD -25.93%
BANX -11.16%
Spread: +14.77 pp (BANX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ACAD TTM Op. Margin: 10.2%
BANX TTM Op. Margin: 75.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACAD vs BANX. Trailing 12-month operating profitability (ACAD 10.2% vs BANX 75.4%) and valuation multiples (ACAD 15.8x vs BANX 14.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACAD | BANX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.0B | $183.4M | Larger Scale | ACAD |
| Trailing P/E Ratio Valuation | 8.3x | 17.7x | Lower Multiple | ACAD |
| Forward P/E Ratio Valuation | 15.8x | 14.6x | Lower Multiple | BANX |
| Revenue Growth (YoY) Growth | +22.8% | -0.2% | Higher Growth | ACAD |
| Operating Margin (TTM) Profitability | 10.2% | 75.4% | Higher Margin | BANX |
| Net Profit Margin Profitability | 30.1% | 50.8% | Higher Margin | BANX |
| Return on Equity (ROE) Capital Efficiency | 31.4% | 7.4% | Higher ROE | ACAD |
| 52-Week Range Position Momentum | 8% ($16โ$31) | 8% ($18โ$22) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 0.15ฮฒ ยท 90% Vol | 0.19ฮฒ ยท 12% Vol | Lower Realized Risk | BANX |
| Unified Institutional Score Composite Signal | 44.8 / 100 (HOLD) | 39.5 / 100 (SELL) | Higher Composite | ACAD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ACAD vs BANX Buy Guide
ACAD
BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
BANX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
14th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ACAD nor BANX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.